Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 23, 2025, Titan Pharmaceuticals (TTNP) has a market cap of $3.108 million USD. According to our data, Titan Pharmaceuticals is ranked No.9138 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 23, 2025 | $3.11 M |
4.29%
|
| Dec 31, 2024 | $2.98 M |
-60.24%
|
| Dec 29, 2023 | $7.50 M |
-47.44%
|
| Dec 30, 2022 | $14.26 M |
-23.53%
|
| Dec 31, 2021 | $18.65 M |
-69.00%
|
| Dec 31, 2020 | $60.16 M |
-42.28%
|
| Dec 31, 2019 | $0.10 B |
-85.61%
|
| Dec 31, 2018 | $0.72 B |
-83.46%
|
| Dec 29, 2017 | $4.38 B |
-66.75%
|
| Dec 30, 2016 | $13.16 B |
-9.91%
|
| Dec 31, 2015 | $14.61 B |
74.70%
|
| Dec 31, 2014 | $8.36 B |
-24.59%
|
| Dec 31, 2013 | $11.09 B |
-44.55%
|
| Dec 31, 2012 | $20.00 B |
-3.51%
|
| Dec 30, 2011 | $20.73 B |
-4.20%
|
| Dec 31, 2010 | $21.64 B |
-48.48%
|
| Dec 31, 2009 | $42.00 B |
11,450.00%
|
| Dec 31, 2008 | $0.36 B |
-98.81%
|
| Dec 31, 2007 | $30.55 B |
-49.40%
|
| Dec 29, 2006 | $60.37 B |
132.17%
|
| Dec 30, 2005 | $26.00 B |
-55.59%
|
| Dec 31, 2004 | $58.55 B |
10.27%
|
| Dec 31, 2003 | $53.10 B |
104.20%
|
| Dec 31, 2002 | $26.00 B |
-85.42%
|
| Dec 31, 2001 | $178.38 B |
-72.26%
|
| Dec 29, 2000 | $643.16 B |
86.16%
|
| Dec 31, 1999 | $345.49 B |
398.36%
|
| Dec 31, 1998 | $69.33 B |
-32.22%
|
| Dec 31, 1997 | $102.28 B |
-31.82%
|
| Dec 31, 1996 | $150.02 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
 Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
 Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
 Collegium Pharmaceutical
COLL
|
$1.05 B |
0.000 M
|
USA
|
 Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
 Cara Therapeutics
CARA
|
$21.85 M |
0.000 M
|
USA
|
 Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
 Nektar Therapeutics
NKTR
|
$0.17 B |
0.000 M
|
USA
|
 Trevena
TRVN
|
$1.61 M |
0.000 M
|
USA
|
| Market Cap | = | TTNP Stock Price | * | TTNP Shares Outstanding |
| = | $3.40 | * | 0.91 M | |
| = | $3.11 M |